POTUS delivers a major announcement that’s sending shockwaves through the medical and political world — unveiling government findings suggesting a possible link between Tylenol use during pregnancy and autism. Speaking at the White House with HHS Secretary RFK Jr., Trump says the FDA will issue new guidance urging caution for expectant mothers and is promoting additional research, including the use of leucovorin as a potential treatment for some autism symptoms. Pags breaks down the press conference and why it matters. Then, Trazy Beanz joins the program to cut through the noise. A respected writer who’s worked with MAHA, she explains what this announcement really means for families, how the medical establishment is reacting, and why this could reshape the autism conversation moving forward. It’s a deep, fact-driven conversation you won’t want to miss.

Learn more about your ad choices. Visit megaphone.fm/adchoices